Hydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous?

Travel Med Infect Dis. 2020 May-Jun:35:101764. doi: 10.1016/j.tmaid.2020.101764. Epub 2020 May 30.

Authors

Corneliu P Popescu¹, Philip R Fischer²

Affiliations

¹ Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; Dr. Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania.
² Department of Pediatric and Adolescent Medicine, Mayo Clinic, 200 First Street, Rochester, MN, 55905, USA. Electronic address: fischer.phil@mayo.edu.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Azithromycin
Betacoronavirus
COVID-19
COVID-19 Drug Treatment
Coronavirus Infections / drug therapy
Coronavirus Infections / epidemiology*
France
Humans
Hydroxychloroquine*
Pandemics*
Pneumonia, Viral*
Retrospective Studies
SARS-CoV-2

Substances

Hydroxychloroquine
Azithromycin